Form DRS - Draft Registration Statement:
SEC Accession No. 0000950123-21-007570
Filing Date
2021-06-04
Accepted
2021-06-04 17:02:56
Documents
4

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRS 1030668
2 GRAPHIC g166948g01s66.jpg GRAPHIC 66200
3 GRAPHIC g166948g08s10.jpg GRAPHIC 126340
4 GRAPHIC g166948g09t20.jpg GRAPHIC 174910
  Complete submission text file 0000950123-21-007570.txt   1526272
Mailing Address ONE CORPORATE DR., 2ND FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address ONE CORPORATE DR., 2ND FLOOR SOUTH SAN FRANCISCO CA 94080 (800) 466-6059
Aligos Therapeutics, Inc. (Filer) CIK: 0001799448 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DRS | Act: 33 | File No.: 377-04970 | Film No.: 21997233
SIC: 2836 Biological Products, (No Diagnostic Substances)